Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar immunogenicity and safety study in preterm infants
2007-001707-38Phase 3Completed
- Sponsor
- University Hospital
- Start
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease (2 arms), sponsored by University Hospital. Primary endpoints: Immunogenicity after primary vaccination course and Immunogenicity after booster dose. Started Jul 2007; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2007-001707-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001707-38.